Exosens (LON:0EXO)
London
· Delayed Price · Currency is GBP · Price in EUR 35.75
+2.20 (6.56%)
At close: May 5, 2025
Exosens Employees
As of December 31, 2024, Exosens had 1,401 total employees, including 1,214 full-time and 187 part-time employees. The number of employees increased by 169 or 13.72% compared to the previous year.
Employees
1,401
Change (1Y)
169
Growth (1Y)
13.72%
Revenue / Employee
249.15K GBP
Profits / Employee
16.14K GBP
Market Cap
1.57B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,401 | 169 | 13.72% |
| Dec 31, 2023 | 1,232 | 0 | - |
| Dec 31, 2021 | 1,232 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| HSBC Holdings | 211,304 |
| Shell | 96,000 |
| Unilever | 115,964 |
| Rio Tinto Group | 60,000 |
| RELX PLC | 36,400 |
| Rolls-Royce Holdings | 42,400 |
| British American Tobacco p.l.c. | 48,989 |
Exosens News
- 17 days ago - Exosens reaffirms 2024 outlook as NATO demand lifts sales - Seeking Alpha
- 5 weeks ago - Exosens: Spectral And Imaging Opportunity With Attractive End Markets - Seeking Alpha